Cellexus raises £945,000 privately and prepares for AIM listing

Investment opportunity

Cellexus Biosystems plc, which specialises in developing disposable equipment for use in bioprocessing raised £945,000 in convertible loan notes and announced plans to list on London’s Alternative Investment Market.

At the same time the company said it plans to move to purpose-designed laboratories in Huntingdon, Cambridgeshire, and is setting up a US customer support centre in Pennsylvania.

CEO Kevin Auton said, “This funding package is a crucial move forward in our growth strategy. We have attracted a number of blue-chip institutional investors in this round, positioning Cellexus for its planned IPO on AIM, which will provide greater liquidity and access to capital to fund our continued development.”